Brian Wynne
- Infectious Diseases top 0.5%
- Virology top 0.5%
- Epidemiology top 5%
- Emergency Medicine top 1%
- Molecular Biology
- Co-authors
- Keith A. PappaCatherine GranierSharon WalmsleySherene MinMichael AboudGarrett NicholsLaurent HocquelouxJulie Borland
- Topics
- HIV/AIDS drug development and treatment (59 papers)HIV Research and Treatment (38 papers)HIV/AIDS Research and Interventions (22 papers)
- Journals
- New England Journal of MedicineThe LancetSHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Brian Wynne
64 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Infectious Diseases 2.0k
- Virology 1.4k
- Epidemiology 651
- Emergency Medicine 617
- Molecular Biology 185
Countries citing papers authored by Brian Wynne
This map shows the geographic impact of Brian Wynne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Wynne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Wynne more than expected).
Fields of papers citing papers by Brian Wynne
This network shows the impact of papers produced by Brian Wynne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Wynne. The network helps show where Brian Wynne may publish in the future.
Co-authorship network of co-authors of Brian Wynne
This figure shows the co-authorship network connecting the top 25 collaborators of Brian Wynne. A scholar is included among the top collaborators of Brian Wynne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Wynne. Brian Wynne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | Switching to dolutegravir/lamivudine (DTG/3TC) fixed-dose combination (FDC) is non-inferior to continuing a tenofovir alafenamide (TAF)-based regimen (TBR) in maintaining virological suppression through 96 weeks (TANGO study) | 0 |
| 8 | 7 | |
| 9 | 6 | |
| 10 | The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet | 1 |
| 11 | Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studiesbreakdown → | 243 |
| 12 | 43 | |
| 13 | 23 | |
| 14 | 5 | |
| 15 | 48 | |
| 16 | Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infectionbreakdown → | 593 |
| 17 | 15 | |
| 18 | 50 | |
| 19 | 98 | |
| 20 | 35 |
About Brian Wynne
Brian Wynne is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 70 papers that have together received 2.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (38 papers) and HIV/AIDS Research and Interventions (22 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (2.0k citations) and Emergency Medicine (617 citations). Brian Wynne has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Keith A. Pappa, Catherine Granier, Sharon Walmsley, Sherene Min, Michael Aboud, Garrett Nichols, Laurent Hocqueloux, Julie Borland, Félix Gutiérrez and Antonio Antela. Their work appears in journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.